NASDAQ:CYRX - Nasdaq - US2290503075 - Common Stock - Currency: USD
5.86
+0.4 (+7.33%)
The current stock price of CYRX is 5.86 USD. In the past month the price increased by 7.72%. In the past year, price decreased by -63.26%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 19.34 | 159.89B | ||
DHR | DANAHER CORP | 26.72 | 142.45B | ||
A | AGILENT TECHNOLOGIES INC | 20.46 | 30.97B | ||
IQV | IQVIA HOLDINGS INC | 13.78 | 27.06B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 27.19 | 22.92B | ||
WAT | WATERS CORP | 29.52 | 20.85B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.82 | 15.18B | ||
ILMN | ILLUMINA INC | 31.79 | 12.33B | ||
ICLR | ICON PLC | 10.42 | 11.80B | ||
RVTY | REVVITY INC | 19.06 | 11.29B | ||
TEM | TEMPUS AI INC | N/A | 9.87B | ||
QGEN | QIAGEN N.V. | 19.52 | 9.32B |
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm enables manufacturers, contract manufacturers, contract research organizations, developers, and researchers to carry out their respective business with products and services. The company provides a range of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories.
CRYOPORT INC
112 Westwood Place, Suite 350
Brentwood TENNESSEE 37027 US
CEO: Jerrell W. Shelton
Employees: 1098
Phone: 19492321900
The current stock price of CYRX is 5.86 USD. The price increased by 7.33% in the last trading session.
The exchange symbol of CRYOPORT INC is CYRX and it is listed on the Nasdaq exchange.
CYRX stock is listed on the Nasdaq exchange.
16 analysts have analysed CYRX and the average price target is 11.5 USD. This implies a price increase of 96.3% is expected in the next year compared to the current price of 5.86. Check the CRYOPORT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CRYOPORT INC (CYRX) has a market capitalization of 293.82M USD. This makes CYRX a Micro Cap stock.
CRYOPORT INC (CYRX) currently has 1098 employees.
CRYOPORT INC (CYRX) has a support level at 5.45 and a resistance level at 5.87. Check the full technical report for a detailed analysis of CYRX support and resistance levels.
The Revenue of CRYOPORT INC (CYRX) is expected to decline by -9.7% in the next year. Check the estimates tab for more information on the CYRX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CYRX does not pay a dividend.
CRYOPORT INC (CYRX) will report earnings on 2025-05-07, after the market close.
CRYOPORT INC (CYRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.16).
The outstanding short interest for CRYOPORT INC (CYRX) is 5.38% of its float. Check the ownership tab for more information on the CYRX short interest.
ChartMill assigns a technical rating of 1 / 10 to CYRX. When comparing the yearly performance of all stocks, CYRX is a bad performer in the overall market: 91.22% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to CYRX. The financial health of CYRX is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months CYRX reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS increased by 47.27% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -17.45% | ||
ROE | -30.54% | ||
Debt/Equity | 0.46 |
ChartMill assigns a Buy % Consensus number of 79% to CYRX. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -4.24% and a revenue growth -9.7% for CYRX